https://www.selleckchem.com/products/ly333531.html
53, 95% CI .07-32.2) and estrogen-containing hormonal contraceptive users (aOR 3.9, 95 % CI .20-76.5). Risk of osteoporosis was elevated among women with CF who used depot-medroxyprogesterone acetate compared to non-users (OR 5.36, 95% CI 1.00-29.12). CONCLUSIONS Both contraceptive use and unplanned pregnancy among women with CF are common. Associations between hormonal contraceptive use and adverse pulmonary or bone outcomes among women with CF are inconclusive due to the study's small sample size. Larger studies are warranted. IMPLIC
Respect!
Kommentar
Delen
